TuHURA BIOSCIENCES, INC./NV Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value
TuHURA BIOSCIENCES, INC./NV (HURA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value of $1.12 per share for the 12-month period ending 2020-06-30, per its 10-K filed 2020-09-18.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue · last filed 2020-09-18
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for the quarter ending 2018-09-30 was $1.01.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for the quarter ending 2016-09-30 was $2.19.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2020 was $1.12, a 85.36% decline from fiscal 2019.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2019 was $7.65, a 0.00% change from fiscal 2018.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2018 was $7.65, a 208.47% increase from fiscal 2017.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2017 was $2.48, a 18.66% increase from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|---|---|---|
| 2020-06-30 | $1.12 10-K · filed 2020-09-18 | ||||
| 2020-03-31 | $1.18 10-Q · filed 2020-05-13 | ||||
| 2019-12-31 | $1.90 10-Q · filed 2020-02-13 | ||||
| 2019-06-30 | $7.65 10-K · filed 2020-09-18 | $15.02 10-K · filed 2019-09-09 | |||
| 2019-03-31 | $7.88 10-Q · filed 2019-05-14 | ||||
| 2018-12-31 | $0.81 10-Q · filed 2019-02-11 | ||||
| 2018-09-30 | $1.01 10-Q · filed 2018-11-13 | ||||
| 2018-06-30 | $7.65 10-K · filed 2019-09-09 | $1.50 10-K · filed 2018-09-24 | |||
| 2017-06-30 | $2.48 10-K · filed 2018-09-24 | ||||
| 2017-03-31 | $2.26 10-Q · filed 2017-05-12 | ||||
| 2016-12-31 | $2.19 10-Q · filed 2017-02-10 | ||||
| 2016-09-30 | $2.19 10-Q · filed 2016-11-10 | ||||
| 2016-06-30 | $2.09 10-K · filed 2017-09-27 | ||||
| 2016-03-31 | $0.64 10-Q · filed 2016-05-12 | ||||
| 2015-06-30 | $1.92 10-K · filed 2016-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |